Highlighted transactions



Collegium Pharmaceutical, Inc.

Piper Sandler served as joint bookrunner on the $69.6 million IPO for Collegium Pharmaceuticals, Inc.

Client Description

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company developing and planning to commercialize next-generation abuse-deterrent products that incorporate the company's patented DETERx® platform technology for the treatment of chronic pain and other diseases.